PARP1 and actinic keratosis: We demonstrated significantly higher PARP1 expression in BCC lesions compared with benign, precancerous (actinic keratosis), and inflammatory lesions, which would result in lower PARPi-FL binding and signaling in the latter compared with BCC lesions in vivo.